Celecoxib Capsules

Award Notice Posted

Solicitation number
SPE2D2-26-D-0010
Agency
Awarded
to Radha Pharmaceuticals Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
SPE2D2-26-D-0010 Federal IDV award
Place of performance
Hauppauge, New York 11788, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Defense Logistics Agency Troop Support Medical awarded contract SPE2D2-26-D-0010 to Radha Pharmaceuticals Inc. on March 19, 2026, for the supply of Celecoxib capsules in six different dosage strengths (50 MG, 100 MG, 200 MG, and 400 MG) with various package sizes. The firm-fixed-price requirements contract has an estimated total value of $15,771,598.00 over a five-year period consisting of one base year and four option years, with unit prices ranging from $2.80 to $25.00 per unit. The contract encompasses six line items with quantities ranging from 2,479 to 91,006 units across all contract years, with delivery specified in bottle quantities through DLA and Pharmaceutical Prime Vendors. Products will be manufactured by ScieGen Pharmaceuticals Inc., located in Hauppauge, New York, and the award was made following competitive evaluation, with Radha Pharmaceuticals Inc.'s proposal determined to be the lowest price technically acceptable.

Notice text

SPE2D2-26-D-0010 Celecoxib Capsules

Awarded contract SPE2D2-26-D-0010 to Radha Pharmaceuticals Inc for 15771598.00 on 2026-03-19.

Files

File Type Posted
Award Document - Celecoxib SPE2D2-26-D-0010.pdf PDF

Notice history

Notice Type Posted
This notice Award Award Notice
Celecoxib Capsules Latest solicitation Solicitation
Celecoxib Capsules Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity